Il Yang Bio Nabumetone Tablet

Adult dose

This medicine is for oral use. Swallow without chewing (tablets only). ○ Adults : Administer 1 g of nabumetone orally once daily at bedtime. If symptoms are severe or persistent, or worsen rapidly, an additional 500 mg∼1 g of this medicine may be administered orally in the morning. ○ Elderly patients : As with many other medicines, plasma concentrations may be higher in elderly patients. Do not exceed a maximum daily dose of 1 g; in some cases, a dose of 500 mg may provide satisfactory relief of symptoms.

Child dose

○ Children : Clinical data on the use of this preparation in children are not yet available.

This medication should be discussed with a doctor or pharmacist before use by individuals who regularly consume more than three glasses of alcohol per day, as there is an increased risk of gastrointestinal bleeding when taken with alcohol. This medication can affect the cardiovascular system, which may increase the risk of serious cardiovascular diseases such as myocardial infarction or stroke. Patients with a history of cardiovascular disease or risk factors should be particularly cautious, and cardiovascular symptoms should be closely monitored during treatment. This medication can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforation. Particularly, elderly patients or those with a history of gastrointestinal disease may be at greater risk and should start at the minimum dose and closely monitor for adverse symptoms. Patients with peptic ulcers, severe blood disorders, liver dysfunction, kidney dysfunction, or heart disease, as well as those with hypersensitivity to this medication or its components, should not take this medication. Additionally, patients with aspirin-induced asthma or those who have had allergic reactions to aspirin or non-steroidal anti-inflammatory drugs should not be given this medication. Patients with abnormalities in blood, liver, or kidney functions or chronic diseases should use this medication with caution and regularly check for abnormalities. Furthermore, patients with chronic inflammatory diseases should be attentive to changes in liver function test results. This medication can rarely cause serious hypersensitivity reactions such as shock or anaphylaxis, and if such symptoms occur, administration should be stopped immediately and appropriate treatment sought. Various side effects such as abdominal pain, nausea, vomiting, diarrhea, headache, dizziness, liver function abnormalities, kidney function abnormalities, respiratory distress, and skin rashes may occur, and if symptoms arise, consultation with a physician is advised. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication, and it should also not be administered to children and adolescents (under 15 years old). This medication may interact with other non-steroidal anti-inflammatory drugs, anticoagulants, diuretics, lithium, methotrexate, and should be discussed with a healthcare professional if taken alongside other medications. Dizziness, drowsiness, and visual disturbances may occur during administration, so it is advisable to avoid driving or operating dangerous machinery. In case of overdose, serious symptoms such as headache, nausea, vomiting, gastrointestinal bleeding, and coma may occur, and prompt medical attention should be sought.

• Shock
• anaphylactic-like symptoms
• respiratory distress
• urticaria
• hypotension
• angioedema
• facial swelling
• rash
• itching
• dyspepsia

This medication should be stored in a tightly closed container to prevent air exposure, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain its efficacy and prevent degradation.

Appearance

Yellow, oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle